litlas
Log inCreate account

Donald Küfe

Active 1972–2025

Also published as
Donald Kufe
246
Papers
39,663
Citations
124
h-index
243
i10-index

Citations

Citations per year for Donald Küfe1972: 11 citations1973: 10 citations1974: 7 citations1975: 2 citations1976: 4 citations1978: 2 citations1979: 1 citations1981: 9 citations1982: 10 citations1983: 15 citations1984: 38 citations1985: 23 citations1986: 31 citations1987: 31 citations1988: 55 citations1989: 85 citations1990: 84 citations1991: 117 citations1992: 110 citations1993: 130 citations1994: 130 citations1995: 148 citations1996: 158 citations1997: 275 citations1998: 319 citations1999: 454 citations2000: 525 citations2001: 505 citations2002: 558 citations2003: 560 citations2004: 504 citations2005: 400 citations2006: 372 citations2007: 415 citations2008: 249 citations2009: 380 citations2010: 267 citations2011: 297 citations2012: 269 citations2013: 265 citations2014: 276 citations2015: 209 citations2016: 177 citations2017: 233 citations2018: 129 citations2019: 551 citations2020: 641 citations2021: 583 citations2022: 685 citations2023: 399 citations2024: 590 citations2025: 256 citations2026: 3 citations1977: no citations, so this year is not shown1980: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,118 citing papers, 39.9% of this breakdownChina: 993 citing papers, 9.6% of this breakdownUnited Kingdom: 577 citing papers, 5.6% of this breakdownGermany: 486 citing papers, 4.7% of this breakdownJapan: 437 citing papers, 4.2% of this breakdownFrance: 372 citing papers, 3.6% of this breakdownItaly: 327 citing papers, 3.2% of this breakdownCanada: 303 citing papers, 2.9% of this breakdownAustralia: 219 citing papers, 2.1% of this breakdownIndia: 178 citing papers, 1.7% of this breakdownSpain: 176 citing papers, 1.7% of this breakdownNetherlands: 170 citing papers, 1.7% of this breakdown
0%39.9%Other 19.1%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology47.3%
  • Medicine36%
  • Immunology and Microbiology11.3%
  • Neuroscience1.3%
  • Engineering0.7%
  • Chemistry0.6%
  • Other2.8%

Topics

  • Cell death mechanisms and regulation3.3%
  • Immunotherapy and Immune Responses3.3%
  • Glycosylation and Glycoproteins Research2.8%
  • Cancer Immunotherapy and Biomarkers2%
  • Cancer-related Molecular Pathways1.8%
  • CAR-T cell therapy research1.8%
  • Other85%

Coauthors

All papers

Open in search
  1. Mucins in cancer: function, prognosis and therapy

    Authors: Donald Küfe - Nature reviews. Cancer 2009 cited by 1,405

  2. MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast Cancer

    Authors: Takahiro Maeda, Masayuki Hiraki, Caining Jin, Hasan Rajabi, Ashujit Tagde, Maroof Alam, Audrey Bouillez, Xiufeng Hu, Yozo Suzuki, Masaaki Miyo, Tsuyoshi Hata, Kunihiko Hinohara, Donald Küfe - Cancer Research 2017 cited by 274

  3. A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas

    Authors: David S. Hong, Razelle Kurzrock, Jeffrey G. Supko, Xiaoying He, Aung Naing, Jennifer J. Wheler, Donald P. Lawrence, Joseph P. Eder, Colin J. Meyer, Deborah A. Ferguson, James W. Mier, Marina Konopleva, Sergej Konoplev, Michael Andreeff, Donald Küfe, Hillard Lazarus, Geoffrey I. Shapiro, Bruce J. Dezube - Clinical Cancer Research 2012 cited by 232

  4. Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells

    Authors: Masanori Hasegawa, Hidekazu Takahashi, Hasan Rajabi, Maroof Alam, Yozo Suzuki, Yin Li, Ashujit Tagde, Takahiro Maeda, Masayuki Hiraki, Vikas P. Sukhatme, Donald Küfe - Oncotarget 2016 cited by 199

  5. MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer

    Authors: Yota Yasumizu, Hasan Rajabi, Caining Jin, Tsuyoshi Hata, Sean P. Pitroda, Mark D. Long, Masayuki Hagiwara, Wei Li, Qiang Hu, Song Liu, Nami Yamashita, Atsushi Fushimi, Ling Kui, Mehmet Samur, Masaaki Yamamoto, Yan Zhang, Ning Zhang, Deli Hong, Takahiro Maeda, Takeo Kosaka, Kwok‐Kin Wong, Mototsugu Oya, Donald Küfe - Nature Communications 2020 cited by 194

  6. MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia

    Authors: Athalia R. Pyzer, Dina Stroopinsky, Hasan Rajabi, Abigail Washington, Ashujit Tagde, Maxwell Coll, Jacqueline Fung, Mary Paty Bryant, Leandra Cole, Kristen Palmer, Poorvi Somaiya, Rebecca Karp Leaf, Myrna Nahas, Arie Apel, Salvia Jain, Malgorzata McMasters, Lourdes Mendez, James D. Levine, Robin Joyce, Jon Arnason, Pier Paolo Pandolfi, Donald Küfe, Jacalyn Rosenblatt, David Avigan - Blood 2017 cited by 192

  7. MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer

    Authors: Nami Yamashita, Mark D. Long, Atsushi Fushimi, Masaaki Yamamoto, Tsuyoshi Hata, Masayuki Hagiwara, Atrayee Bhattacharya, Qiang Hu, Kwok‐Kin Wong, Song Liu, Donald Küfe - Journal for ImmunoTherapy of Cancer 2021 cited by 81

  8. MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells

    Authors: Masayuki Hagiwara, Atsushi Fushimi, Nami Yamashita, Atrayee Bhattacharya, Hasan Rajabi, Mark D. Long, Yota Yasumizu, Mototsugu Oya, Song Liu, Donald Küfe - Oncogene 2021 cited by 71

  9. MUC1-C Activates the BAF (mSWI/SNF) Complex in Prostate Cancer Stem Cells

    Authors: Masayuki Hagiwara, Yota Yasumizu, Nami Yamashita, Hasan Rajabi, Atsushi Fushimi, Mark D. Long, Wei Li, Atrayee Bhattacharya, Rehan Ahmad, Mototsugu Oya, Song Liu, Donald Küfe - Cancer Research 2020 cited by 80

  10. MUC1-C Oncoprotein Functions as a Direct Activator of the Nuclear Factor-κB p65 Transcription Factor

    Authors: Rehan Ahmad, Deepak Raina, Maya Datt Joshi, Takeshi Kawano, Jian Ren, Surender Kharbanda, Donald Küfe - Cancer Research 2009 cited by 190

  11. MUC1-C in chronic inflammation and carcinogenesis; emergence as a target for cancer treatment

    Authors: Donald Küfe - Carcinogenesis 2020 cited by 92

  12. Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions

    Authors: Jacalyn Rosenblatt, Richard M. Stone, Lynne Uhl, Donna Neuberg, Robin Joyce, James D. Levine, Jon Arnason, Malgorzata McMasters, Katarina Luptakova, Salvia Jain, Jeffrey I. Zwicker, Ayad Hamdan, Vassiliki A. Boussiotis, David P. Steensma, Daniel J. DeAngelo, Ilene Galinsky, Poorvi Somaiya Dutt, Emma Logan, Mary Paty Bryant, Dina Stroopinsky, Lillian Werner, Kristen Palmer, Max Coll, Abigail Washington, Leandra Cole, Donald Küfe, David Avigan - Science Translational Medicine 2016 cited by 164

  13. MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC

    Authors: Naoki Haratake, Hiroki Ozawa, Yoshihiro Morimoto, Nami Yamashita, Tatsuaki Daimon, Atrayee Bhattacharya, Keyi Wang, Ayako Nakashoji, Hideko Isozaki, Mototsugu Shimokawa, Chie Kikutake, Mikita Suyama, Asato Hashinokuchi, Kazuki Takada, Tomoyoshi Takenaka, Tomoharu Yoshizumi, Tetsuya Mitsudomi, Aaron N. Hata, Donald Küfe - Journal of Thoracic Oncology 2023 cited by 45

  14. MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer

    Authors: Masayuki Hagiwara, Atsushi Fushimi, Atrayee Bhattacharya, Nami Yamashita, Yoshihiro Morimoto, Mototsugu Oya, Henry G. Withers, Qiang Hu, Tao Liu, Song Liu, Kwok K. Wong, Mark D. Long, Donald Kufe - OncoImmunology 2022 cited by 31

  15. Addiction of Cancer Stem Cells to MUC1-C in Triple-Negative Breast Cancer Progression

    Authors: Nami Yamashita, Donald Küfe - International Journal of Molecular Sciences 2022 cited by 37

  16. MUC1-C is necessary for SHP2 activation and BRAF inhibitor resistance in BRAF(V600E) mutant colorectal cancer

    Authors: Yoshihiro Morimoto, Nami Yamashita, Haruka Hirose, Atsushi Fushimi, Naoki Haratake, Tatsuaki Daimon, Atrayee Bhattacharya, Rehan Ahmad, Yozo Suzuki, Hidekazu Takahashi, Donald Küfe - Cancer Letters 2023 cited by 20

  17. Emergence of MUC1 in Mammals for Adaptation of Barrier Epithelia

    Authors: Donald Küfe - Cancers 2022 cited by 35

  18. Multiparametric profiling of non–small-cell lung cancers reveals distinct immunophenotypes

    Authors: Patrick H. Lizotte, Elena V. Ivanova, Mark M. Awad, Robert E. Jones, Lauren Keogh, Hongye Liu, Ruben Dries, Christina Almonte, Grit S. Herter-Sprie, Abigail Santos, Nora Feeney, Cloud P. Paweletz, Meghana Kulkarni, Adam J. Bass, Anil K. Rustgi, Guo‐Cheng Yuan, Donald Küfe, Pasi A. Jänne, Peter S. Hammerman, Lynette M. Sholl, F. Stephen Hodi, William G. Richards, Raphael Bueno, Jessie M. English, Mark Bittinger, Kwok‐Kin Wong - JCI Insight 2016 cited by 127

  19. MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer

    Authors: Nami Yamashita, Yoshihiro Morimoto, Atsushi Fushimi, Rehan Ahmad, Atrayee Bhattacharya, Tatsuaki Daimon, Naoki Haratake, Yuka Inoue, Satoshi Ishikawa, Masaaki Yamamoto, Tsuyoshi Hata, Sayuri Akiyoshi, Qiang Hu, Tao Liu, Henry Withers, Song Liu, Geoffrey I. Shapiro, Tomoharu Yoshizumi, Mark D. Long, Donald Küfe - Molecular Cancer Research 2022 cited by 35

  20. MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells

    Authors: Yoshihiro Morimoto, Nami Yamashita, Tatsuaki Daimon, Haruka Hirose, Shizuka Yamano, Naoki Haratake, Satoshi Ishikawa, Atrayee Bhattacharya, Atsushi Fushimi, Rehan Ahmad, Hidekazu Takahashi, Olga Dashevsky, Constantine S. Mitsiades, Donald Küfe - Journal for ImmunoTherapy of Cancer 2023 cited by 25

  21. PD-1 Blockade by CT-011, Anti-PD-1 Antibody, Enhances Ex Vivo T-cell Responses to Autologous Dendritic Cell/Myeloma Fusion Vaccine

    Authors: Jacalyn Rosenblatt, Brett Glotzbecker, Heidi Mills, Baldev Vasir, Dimitrios Tzachanis, James D. Levine, Robin Joyce, Kerry Wellenstein, Whitney Keefe, Michael Schickler, Rinat Rotem‐Yehudar, Donald Küfe, David Avigan - Journal of Immunotherapy 2011 cited by 282

  22. Triterpenoid CDDO-Me Blocks the NF-κB Pathway by Direct Inhibition of IKKβ on Cys-179

    Authors: Rehan Ahmad, Deepak Raina, Colin J. Meyer, Surender Kharbanda, Donald Küfe - Journal of Biological Chemistry 2006 cited by 233

  23. MUC1 oncoprotein activates the IκB kinase β complex and constitutive NF-κB signalling

    Authors: Rehan Ahmad, Deepak Raina, Vishal Trivedi, Jian Ren, Hasan Rajabi, Surender Kharbanda, Donald Küfe - Nature Cell Biology 2007 cited by 175

  24. MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer Cells

    Authors: Tsuyoshi Hata, Hasan Rajabi, Hidekazu Takahashi, Yota Yasumizu, Wei Li, Caining Jin, Mark D. Long, Qiang Hu, Song Liu, Atsushi Fushimi, Nami Yamashita, Ling Kui, Deli Hong, Masaaki Yamamoto, Masaaki Miyo, Masayuki Hiraki, Takahiro Maeda, Yozo Suzuki, Mehmet Samur, Donald Küfe - Cancer Research 2019 cited by 72